An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent Patients

Clinical trial NCT04971291 · UNKNOWN

Trial details

NCT number: NCT04971291
Sponsor: Axsome Therapeutics, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder Treatment Resistant Depression

Start date: 2021-04-14
Primary completion: 2021-07-01
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.